Sponsor

Collegium Medicum w Bydgoszczy

Clinical research sponsor

Published trials3
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

3 shown
Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent RehospitalizationsNCT03764722 · lead sponsor · 2018-08-01
UNKNOWN
Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical ProstatectomyNCT03061760 · lead sponsor · 2017-03-01
UNKNOWN
FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).NCT01332526 · lead sponsor · 2011-05-01
UNKNOWN

Sponsor roles

lead sponsor3

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.